Share This Article:

Autonomic Neuropathy in HIV: A Case Report and Review of Potential Symptoms in an Advanced-Stage, HIV Cohort

Abstract Full-Text HTML Download Download as PDF (Size:186KB) PP. 265-269
DOI: 10.4236/wja.2012.23035    3,993 Downloads   7,106 Views   Citations

ABSTRACT

A woman with a seventeen-year history of HIV infection on effective antiretroviral therapy presented with signs and symptoms of distal symmetric polyneuropathy (DSP). She developed significant side effects (dizziness, nausea, edema) with medications for pain management. Chart review revealed a history of similar intolerance to multiple antiretrovirals, which was not explained by known cardiac or gastrointestinal disease or psychological factors. Specialized testing revealed the presence of an autonomic neuropathy, which provided an explanation for her medication intolerance. The patient was educated on the symptoms of autonomic neuropathy and its relationship to DSP and subsequent symptomatic medications were initiated at the lowest possible doses. Although symptom management remained challenging, the patient exhibited lower frustration and greater acceptance of medication trials. Review of 168 advanced stage HIV infected individuals demonstrated that 81% experienced at least one, and 33% three or more, symptoms potentially attributable to autonomic neuropathy. Potentially autonomic symptoms were significantly associated with the presence of symptomatic DSP. Autonomic neuropathy is difficult to diagnose without specialized testing, as its symptoms are non-specific and overlap with a large number of somatic disorders. The high prevalence of autonomic-type symptoms in chronic HIV, and their association with peripheral neuropathy, may warrant further investigation of the potential for autonomic dysfunction in individuals with HIV-related symptomatic DSP.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

J. Robinson-Papp, K. J. Elliott, M. Pizzirusso and S. Morgello, "Autonomic Neuropathy in HIV: A Case Report and Review of Potential Symptoms in an Advanced-Stage, HIV Cohort," World Journal of AIDS, Vol. 2 No. 3, 2012, pp. 265-269. doi: 10.4236/wja.2012.23035.

References

[1] R. J. Ellis, D. Rosario, D. B. Clifford, et al., “Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus-Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy: The CHARTER Study,” Archives of Neurology, Vol. 67, No. 5, 2010, pp. 552-558. doi:10.1001/archneurol.2010.76
[2] J. Robinson-Papp, B. Gelman, I. Grant, E. Singer, G. Gensler and S. Morgello, “Substance Abuse Increases the Risk of Neuropathy in an HIV-Infected Cohort,” Muscle Nerve, Vol. 45, No. 4, 2012, pp. 471-476. doi:10.1002/mus.23231
[3] S. R. Evans, R. J. Ellis, H. Chen, et al., “Peripheral Neuropathy in HIV: Prevalence and Risk Factors,” AIDS, Vol. 25, No. 7, 2011, pp. 919-928. doi:10.1097/QAD.0b013e328345889d
[4] M. Polydefkis, C. T. Yiannoutsos, B. A. Cohen, et al., “Reduced Intraepidermal Nerve Fiber Density in HIV-Associated Sensory Neuropathy,” Neurology, Vol. 58, No. 1, 2002, pp. 115-119. doi:10.1212/WNL.58.1.115
[5] P. A. Low, “Composite Autonomic Scoring Scale for Laboratory Quantification of Generalized Autonomic Failure,” Mayo Clinic Proceedings, Vol. 68, No. 8, 1993, pp. 748-752.
[6] G. A. Suarez, T. L. Opfer-Gehrking, K. P. Offord, E. J. Atkinson, P. C. O’Brien and P. A. Low, “The Autonomic Symptom Profile: A New Instrument to Assess Autonomic Symptoms,” Neurology, Vol. 52, No. 3,1999, pp. 523-528. doi:10.1212/WNL.52.3.523
[7] S. Morgello, L. Estanislao, D. Simpson, et al., “HIV-Associated Distal Sensory Polyneuropathy in the Era of Highly Active Antiretroviral Therapy: The Manhattan HIV Brain Bank,” Archives of Neurology, Vol. 61, No. 4, 2004, pp. 546-551. doi:10.1001/archneur.61.4.546
[8] C. Compostella, L. Compostella and R. D’Elia, “Cardiovascular Autonomic Neuropathy in HIV-Positive African Patients,” Minerva Cardioangiologica, Vol. 56, No. 4, 2008, pp. 417-428.
[9] D. C. Chow, R. Wood, J. Choi, et al., “Cardiovagal Autonomic Function in HIV-Infected Patients with Unsuppressed HIV Viremia,” HIV Clinical Trials, Vol. 12, No. 3, 2011, pp. 141-150. doi:10.1310/hct1203-141
[10] G. Askgaard, U. S. Kristoffersen, J. Mehlsen, G. Kronborg, A. Kjaer and A. M. Lebech, “Decreased Heart Rate Variability in HIV Positive Patients Receiving Antiretroviral Therapy: Importance of Blood Glucose and Cholesterol,” PLoS One, Vol. 6, No. 5, 2011, Article ID: e20196. doi:10.1371/journal.pone.0020196
[11] R. Freeman, M. S. Roberts, L. S. Friedman and C. Broadbridge, “Autonomic Function and Human Immunodeficiency Virus Infection,” Neurology, Vol. 40, No. 4, 1990, pp. 575-580. doi:10.1212/WNL.40.4.575
[12] S. Ruttimann, P. Hilti, G. A. Spinas and U. C. Dubach, “High Frequency of Human Immunodeficiency Virus-Associated Autonomic Neuropathy and More Severe Involvement in Advanced Stages of Human Immunodeficiency Virus Disease,” Archives of Internal Medicine, Vol. 151, No. 12, 1991, pp. 2441-2443. doi:10.1001/archinte.1991.00400120079013

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.